CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU

Similar documents
EU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH

What EU research policy can do for conditions such as chronic pain?

Brain research supported by the European Union

Maltese Presidency of the Council of the European Union. Ministry for Health

Horizon Introduction. Alex Harris Medical Research Council

Future of diabetes research in the EU- the EC perspectives

Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation

Cancer prevention and control in the context of an integrated approach

Cancer Control Joint Action, Improving Outcomes for Cancer Patients and the European Cancer Patient s Bill of Rights

COMMISSION OF THE EUROPEAN COMMUNITIES

Action plan for the health sector response to viral hepatitis in the WHO European Region

Non communicable diseases

Future of Diabetes Research in Europe JDRF Perspective

Priority Medicines for Europe and the World: Setting a public health based medicines development agenda

COMMISSION OF THE EUROPEAN COMMUNITIES

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

Gesundheit in Horizont 2020

Magyar Nemzeti Szívalapítvány Hungarian National Heart Foundation

The EU strategy in Horizon2020 to fight poverty related diseases

On the occasion of World Digestive Health Day 2013: The importance of research into liver cancer and alcohol as a risk factor

PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH

New Horizons for Vaccine R&D&I in Europe

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

ONTARIO CANCER PLAN

Council of the European Union Brussels, 28 October 2015 (OR. en)

An example of intersectoral collaboration: the EU model. European Commission Health and Consumers Directorate-General (DG SANCO)

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)

Cancer Research in the EU Framework Programmes for RTD

Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee

Informal Meeting of Health Ministers March, 2017 Grand Master s Palace, Valletta MEDIA BACKGROUND NOTE

Health related issues in Moldova. Stanislav Groppa, MD, PhD, Prof., Acad. Victor Vovc, MD, PhD, Prof.

Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board

Multi-sectoral aspects of pandemic preparedness and response

Translating Duke Health. Accelerating discovery and its translation

Midland Region All Boards Development Days. Midland Cancer Network. 15, 16 October, 2015

NORDIC CONFERENCE ON RARE DISEASES

14414/15 AF/evt 1 DG G 3 C

Service Improvement - Strategic. Service Improvement - Strategic. Regional Oncology Communications and Health Promotions

Draft resolution submitted by the President of the General Assembly

Changing the prevention paradigm for the future what Europe can do

S05-1 Social-economic impact of diabetes in New Zealand

JPI A healthy diet for a healthy life. JPI: concept and benefits Vision Research areas Governance

Lessons learnt from cancer screening programmes as an example for establishing the Czech National Coordination Centre

The Life Course Immunisation Initiative

Prevention and control of hepatitis B and C in the European Region of WHO

POSITION PAPER PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE

Welcome Note by Dr. Helge Braun, Parliamentary State Secretary

COMMISSION OF THE EUROPEAN COMMUNITIES

Botswana Private Sector Health Assessment Scope of Work

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

Monitoring of the achievement of the health-related Millennium Development Goals

For More Information Visit:

Health and. Consumers

Draft resolution proposed by Brazil, Colombia, Costa Rica, Egypt, Republic of Moldova and South Africa

Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective

The European Asthma Research & Innovation Partnership tackling Europe s high asthma prevalence and death rates

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

National Strategy. for Control and Prevention of Non - communicable Diseases in Kingdom of Bahrain

The American College of Obstetricians and Gynecologists Office of Global Women s Health Strategic Plan

The National perspective Public Health England s vision, mission and priorities

Counting down to zero

Program Priorities 2018

2014 Towards an HIV Cure symposium Melbourne The Role of a Public-Private Partnership in HIV Cure

Cancer prevention and control

British Association of Stroke Physicians Strategy 2017 to 2020

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022

Cancer and Nutrition NIHR infrastructure collaboration. Alan Jackson NIHR Director for Nutrition Research

The European Framework Program for Research & Innovation: Horizon 2020: Health, demographic change & wellbeing

Horizon Tailored screening as a research challenge. Mireille Broeders 30 January 2014, Bologna

ASIA-PACIFIC HEART HEALTH CHARTER

Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed

Viral Hepatitis B and C in North African Countries

EuropaColon Expands into Digestive Cancers Europe. Our objective is to save an additional 250,000 Europeans every year

Intensifying our efforts towards a world free of the avoidable burden of NCDs

Strengthening Health Systems and Blood Services

CONSENSUS STATEMENT OF THE NATIONAL FOOD AND NUTRITION SUMMIT 2018, LUSAKA, ZAMBIA

Global Strategies to Improve Cancer Care and Control

Introduction to the POWER Study Chapter 1

Type 1 Diabetes Australian Research Impact Analysis

Pain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki

Open Access to publications and research data in Horizon 2020

Moving towards 2020 priorities for Public Health for the years Health and Consumers

Copenhagen, Denmark, September August Malaria

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE

A progress report on the Joint Programming Initiative

Commissioner Margrethe Vestager, European Commission Rue de la Loi 170, 1049 Brussels

The elements of cancer and palliative care reform in Victoria

Driving Improvement in Healthcare Our Strategy

European Dietetic Action Plan EuDAP ( )

Fifth report of Committee A

Viral Hepatitis Prevention Board CREATIVE FINANCING SOLUTIONS TO SCALE UP PREVENTION & TREATMENT OF HBV/HCV

MEN S HEALTH AND PRIMARY CARE: IMPROVING ACCESS AND OUTCOMES

BRAIN MISSION Understand - fix - enhance

RESOLUTIONS. Comprehensive and coordinated efforts for the management of autism spectrum disorders

PAEDIATRIC ASSOCIATION OF NIGERIA & CONTRIBUTIONS TO IMMUNIZATIONS IN NIGERIA

Setting the Context: Understanding the Numbers, Vulnerable Populations and Federal Public Health Policy

Introduction to Wessex AHSN Cathy Rule Project Manager Alcohol Quality Improvement Programme. 25 th June 2014

Transcription:

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU July December 2012 Research Symposium on Digestive and Liver Diseases Brussels, 18 September 2012 Dr Myrto Azina- Chronides Ministry of Health Cyprus

Digestive and Liver Diseases Digestive system: Can be affected by a wide diversity of acute and chronic diseases. It can affect individuals of any age, race or ethnicity, gender, or socioeconomic status. Burden on healthcare systems. Associated with significant mortality, morbidity, and loss of quality of life, impact on patients ability to work / engage in everyday activities.

Main Diseases/ Epidemiological Data in Europe Liver diseases: Viral infections : Mainly Hepatitis forms: Hepatitis A Hepatitis B Hepatitis C Alcohol: Cirrhosis and Hepatoma Nutrition: Fatty liver Drugs and toxins: cirrhosis or hepatitis/hepatoma Immune system Genetic conditions: haemochromatosis, Wilson s Disease, Gilbert s syndrome etc. Prevalence of liver diseases: approximately 6% in the EU (29 million people). Mortality rates: vary (53.6 per 100.000 Hungary, 4.4 per 100.000 Netherlands)

Epidemiological Data in Europe Digestive diseases: colorectal cancer mortality rate:200.000 Pancreas Cancer mortality rate: 60.000 Oesophagus Cancer mortality rate: 30.000 Non-malignant diseases: Crohn s disease, irritable bowel syndrome, coeliac disease human and financial burden.

How can we reduce the burden? A comprehensive and holistic Control strategy should be introduced that focuses on: Primary Prevention Secondary Prevention Accelerated Diagnosis procedures and contemporary Diagnosis Measures Therapy based on guidelines and protocols Palliative Care and Research

Focus on Research Health Research: Many breakthrough discoveries that have advanced our understanding of digestive system biology and function. Improve health and quality of life of many people with digestive diseases. Safeguard the sustainability of Healthcare Systems (cost effective solutions). Reduce inequalities (within and between MS).

Research Achievement examples Molecular signaling pathways: genetic basis of colorectal cancer Stem cell research: future clinical applications in digestive disease therapy. Development and licensing of two rotavirus vaccines Endoscopic imaging techniques Identification of genes that increase susceptibility to inflammatory bowel diseases. Identification of the microbe Helicobacter pylori as a cause of peptic ulcer disease.

Health Research and Innovation in Europe The aim of the EU investment in Health research is to improve the health of European citizens, address global health issues and boost the competitiveness of European healthrelated industries. Seventh Framework Programme (FP7): Various chronic diseases: inflammatory bowel disease and fatty liver disease/cancer

Health Research in Europe II-facts and challenges Societal impact EU funding for health represents 10% of the overall EU research funding budget(usa:>3.5x)- Brain Drain! Multidisciplinary collaboration should be encouraged Coordinating strategy among various stakeholders (PPP) Develop international partnerships in order to increase competitiveness Safeguard sustainability

Future developments in the most important fields Increase knowledge base for understanding health and digestive diseases. Translate new knowledge for the direct benefit of patients. Develop research resources (synergy between different funding programmes) and infrastructure. Give incentives and opportunities for future research investigators.

The Cyprus Presidency Main Health Priority: Towards a Better Health for All Invest in Actions that will: Identify the importance of innovation in the provision of high quality, cost-efficient healthcare services Assure healthy ageing across the lifecycle Enable cross-sectoral collaboration Introduce patient centred healthcare InnovaHealth Conference, 11-13.10. 2012, Larnaca, Cyprus, focuses on: A) Personalised Medicine B) Preventive Health and Wellness C) ehealth D) Nutrition and Health care E) Building an Open Innovation ecosystem for Health Care

The Cyprus Presidency Main Presidency Health Related Events in Cyprus Presidency Conference on Communicable Diseases 5 th July 2012 Informal Meeting of the Ministers of Health 10 th 11 th July 2012 High-Level Conference on Healthy Ageing 5 th 6 th September 2012 INNOVAHEALTH Conference 11 th 13 th October 2012 Chief Medical, Chief Nursing and Chief Dental Officers Meeting 9 th 10 th October 2012 Annual meeting of the Advisory Forum of EFSA 5 th 7 th December 2012

By seeking and blundering we learn Goethe!